Where will Prince Philip be buried, will he have a state funeral and where are other royals buried? The Duke of Edinburgh may have a low-key ceremony.
India’s indigenously developed Covaxin jab 78% effective against Covid-19 in trials, maker Bharat Biotech says
The Covid-19 vaccine developed by Indian pharmaceutical firm Bharat Biotech has been found to be 78% effective in preventing symptoms of Covid-19 and 100% against severe disease in stage three trials, the company said.
In a press release on Wednesday, Bharat Biotech published second-round interim results from stage-three trials of the country’s first indigenous Covid-19 jab. The data, which was based on a trial of more than 25,000 participants, showed the formulation to have 78% efficacy in preventing symptomatic Covid-19 – and totally effective in preventing severe forms of the disease.
"The efficacy data against severe Covid-19 and asymptomatic infections is highly significant, as this helps reduce hospitalizations and disease transmission, respectively,” the company’s boss, Krishna Ella, said in a statement.
Balram Bhargava, secretary of health research & director general of the Indian Council of Medical Research, praised the hard work of the scientists involved and said he was pleased by the jab’s protection against new virus variants.
“I am also happy to note that Covaxin works well against most variants of SARS-CoV-2. These findings together consolidate the position of our indigenous vaccine in the global vaccine landscape,” he stated.